Yates AS - Search Results

1

Towards Better Delivery of Cannabidiol (CBD).

Millar SA, Maguire RF, Yates AS, O'Sullivan SE. Millar SA, et al. Among authors: yates as. Pharmaceuticals (Basel). 2020 Aug 28;13(9):219. doi: 10.3390/ph13090219. Pharmaceuticals (Basel). 2020. PMID: 32872355 Free PMC article. Review.

2

A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans.

Millar SA, Stone NL, Yates AS, O'Sullivan SE. Millar SA, et al. Among authors: yates as. Front Pharmacol. 2018 Nov 26;9:1365. doi: 10.3389/fphar.2018.01365. eCollection 2018. Front Pharmacol. 2018. PMID: 30534073 Free PMC article.

3

A systematic review of cannabidiol dosing in clinical populations.

Millar SA, Stone NL, Bellman ZD, Yates AS, England TJ, O'Sullivan SE. Millar SA, et al. Among authors: yates as. Br J Clin Pharmacol. 2019 Sep;85(9):1888-1900. doi: 10.1111/bcp.14038. Epub 2019 Jul 19. Br J Clin Pharmacol. 2019. PMID: 31222854 Free PMC article.

4

An Analysis of Over-the-Counter Cannabidiol Products in the United Kingdom.

Liebling JP, Clarkson NJ, Gibbs BW, Yates AS, O'Sullivan SE. Liebling JP, et al. Among authors: yates as. Cannabis Cannabinoid Res. 2022 Apr;7(2):207-213. doi: 10.1089/can.2019.0078. Epub 2020 Apr 1. Cannabis Cannabinoid Res. 2022. PMID: 33998849 Free PMC article.

5

The Peripheral Cannabinoid Receptor Type 1 (CB₁) as a Molecular Target for Modulating Body Weight in Man.

O'Sullivan SE, Yates AS, Porter RK. O'Sullivan SE, et al. Among authors: yates as. Molecules. 2021 Oct 13;26(20):6178. doi: 10.3390/molecules26206178. Molecules. 2021. PMID: 34684760 Free PMC article. Review.

6

The emerging role of fatty acid binding protein 5 (FABP5) in cancers.

George Warren W, Osborn M, Yates A, Wright K, O'Sullivan SE. George Warren W, et al. Drug Discov Today. 2023 Jul;28(7):103628. doi: 10.1016/j.drudis.2023.103628. Epub 2023 May 23. Drug Discov Today. 2023. PMID: 37230284 Free article. Review.

7

Cancer-Cachexia-Induced Human Skeletal Muscle Myotube Degeneration Is Prevented via Cannabinoid Receptor 2 Agonism In Vitro.

Noone J, Rooney MF, Karavyraki M, Yates A, O'Sullivan SE, Porter RK. Noone J, et al. Pharmaceuticals (Basel). 2023 Nov 8;16(11):1580. doi: 10.3390/ph16111580. Pharmaceuticals (Basel). 2023. PMID: 38004445 Free PMC article.

8

Discovery and Preclinical Evaluation of a Novel Inhibitor of FABP5, ART26.12, Effective in Oxaliplatin-Induced Peripheral Neuropathy.

Warren G, Osborn M, Tsantoulas C, David-Pereira A, Cohn D, Duffy P, Ruston L, Johnson C, Bradshaw H, Kaczocha M, Ojima I, Yates A, O'Sullivan SE. Warren G, et al. J Pain. 2024 Jan 15:S1526-5900(24)00345-6. doi: 10.1016/j.jpain.2024.01.335. Online ahead of print. J Pain. 2024. PMID: 38232863 Free article.

9

The emerging role of fatty acid binding protein 7 (FABP7) in cancers.

George Warren W, Osborn M, Yates A, O'Sullivan SE. George Warren W, et al. Drug Discov Today. 2024 Apr 12;29(5):103980. doi: 10.1016/j.drudis.2024.103980. Online ahead of print. Drug Discov Today. 2024. PMID: 38614160 Free article. Review.

10

New fluorescent adenosine A1-receptor agonists that allow quantification of ligand-receptor interactions in microdomains of single living cells.

Middleton RJ, Briddon SJ, Cordeaux Y, Yates AS, Dale CL, George MW, Baker JG, Hill SJ, Kellam B. Middleton RJ, et al. Among authors: yates as. J Med Chem. 2007 Feb 22;50(4):782-93. doi: 10.1021/jm061279i. Epub 2007 Jan 24. J Med Chem. 2007. PMID: 17249651

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page